System C Healthcare plc
02 December 2005
System C Healthcare plc ("System C" or "the Company")
Trading Statement
In its AGM statement on the 22nd November 2005, System C announced that
rescheduling of deployments in the NHS National Programme for IT ("NPfIT") had
caused volatility in revenue conditions for the Company, but that the outcome of
negotiations about new product and services opportunities could have a
significant impact on the results for the current financial year and beyond.
Whilst the company expected that those negotiations would be concluded in the
short term, it is now aware that the final outcome has been delayed by at least
3 months. Consequently revenue and profits for the year will be significantly
below expectations.
The Company intends to maintain its operational and development capacity to
ensure that it is able to take full advantage of substantial business
opportunities as NPfIT gathers pace, and is well supported in this by a strong
cash and balance sheet position.
The Company's interim results for the period ended 30 November 2005 will be
announced on 25th January 2006.
Enquiries:
System C Healthcare plc
Jim Horsburgh, Chairman 01622 691616
Ian Denley, Chief Executive
Maitland 020 7379 5151
Neil Bennett
Brian Hudspith
This information is provided by RNS
The company news service from the London Stock Exchange
LBDDBUGGGUD
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.